IFRX
InflaRx NV
NASDAQ · Healthcare · Biotechnology · DE
$2.09
+1.46%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.84x
- Price / sales
- —
- Price / cash flow
- -11.26x
Enterprise value
- Enterprise value
- $127.1M
- EV / sales
- —
- EV / EBITDA
- -2.85x
- EV / EBIT
- -3.03x
- Market cap
- $308.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026